Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Louisville, Kentucky · 3415 BARDSTOWN RD STE 202, LOUISVILLE, KY 40218-4605 · (502) 472-8363
Part of Exelixis Clinical
As of July 2026, 1 paid clinical trial is recruiting at Exelixis Clinical in Louisville, Kentucky. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (1)
More research sites in Louisville
- University of Louisville (65 trials)
- The James Graham Brown Cancer Center at University of Louisville (38 trials)
- UofL Health Medical Center Northeast (35 trials)
- Norton Cancer Institute (34 trials)
- Norton Children's Hospital (33 trials)
- Baptist Health Louisville (21 trials)
- University of Louisville Hospital (13 trials)
- Norton Healthcare (9 trials)
- Gastroenterology Health Partners (7 trials)
- Robley Rex VA Medical Center (6 trials)
Explore more
Paid clinical trials in Louisville, KY · Kentucky clinical trials